These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7124287)

  • 1. Metabolic studies in women with previous gestational diabetes during contraceptive treatment: effects on serum lipids and high density lipoproteins.
    Rådberg T; Gustafson A; Skryten A; Karlsson K
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):134-9. PubMed ID: 7124287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic studies in gestational diabetic women during contraceptive treatment: effects on glucose tolerance and fatty acid composition of serum lipids.
    Rådberg T; Gustafson A; Skryten A; Karlsson K
    Gynecol Obstet Invest; 1982; 13(1):17-29. PubMed ID: 7035304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraception in diabetic women. A cross-over study on serum and high density lipoprotein (HDL) lipids and diabetes control during progestogen and combined estrogen/progestogen contraception.
    Rådberg T; Gustafson A; Skryten A; Karlsson K
    Horm Metab Res; 1982 Feb; 14(2):61-5. PubMed ID: 7040192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel.
    Larsson-Cohn U; Wallentin L; Zador G
    Horm Metab Res; 1979 Jul; 11(7):437-40. PubMed ID: 225252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraception in diabetic women. Diabetes control, serum and high density lipoprotein lipids during low-dose progestogen, combined oestrogen/progestogen and non-hormonal contraception.
    Rådberg ; Gustafson A; Skryten A; Karlsson K
    Acta Endocrinol (Copenh); 1981 Oct; 98(2):246-51. PubMed ID: 7027708
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of two low-dose oral contraceptives and non-hormonal contraception on serum lipids and high-density lipoprotein cholesterol.
    Saure A; Heikkinen JE; Ylostalo P
    Contracept Deliv Syst; 1984 Apr; 5(2):83-90. PubMed ID: 12266199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose and lipid metabolism with triphasic oral contraceptives in women with history of gestational diabetes.
    Kung AW; Ma JT; Wong VC; Li DF; Ng MM; Wang CC; Lam KS; Young RT; Ma HK
    Contraception; 1987 Mar; 35(3):257-69. PubMed ID: 3111786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid metabolic studies in oophorectomized women: effects induced by two different estrogens on serum lipids and lipoproteins.
    Silfverstolpe G; Gustafson A; Samsioe G; Svanborg A
    Gynecol Obstet Invest; 1980; 11(3):161-9. PubMed ID: 7439809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
    Nash AL; Cornish EJ; Hain R
    Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of three different combinations of ethinyl estradiol and levonorgestrel on plasma lipids and high density lipoproteins.
    Larsson-Cohn U; Wallentin L; Zador G
    Acta Obstet Gynecol Scand Suppl; 1979; 88():57-60. PubMed ID: 230693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid metabolic studies in women with a polycystic ovary syndrome during treatment with a low-dose desogestrel-ethinylestradiol combination.
    Cullberg G; Hamberger L; Mattsson LA; Mobacken H; Samsioe G
    Acta Obstet Gynecol Scand; 1985; 64(3):203-7. PubMed ID: 3160212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
    Lepot MR; Gaspard UJ
    Int J Fertil; 1987; 32 Suppl():15-20. PubMed ID: 2906343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptives.
    Kuhl H; März W; Jung-Hoffmann C; Heidt F; Gross W
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):363-9. PubMed ID: 2142576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
    März W; Gross W; Gahn G; Romberg G; Taubert HD; Kuhl H
    Am J Obstet Gynecol; 1985 Oct; 153(3):287-93. PubMed ID: 2931988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between levels of blood lipids, vitamins C, A, and E, serum copper compounds, and urinary excretions of tryptophan metabolites in women taking oral contraceptive therapy.
    Horwitt MK; Harvey CC; Dahm CH
    Am J Clin Nutr; 1975 Apr; 28(4):403-12. PubMed ID: 1119436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.